Proteins implicated in muscular dystrophy and cancer are functional constituents of the centrosome

Area of Science:

• Cell Biology
• Molecular Biology
• Genetics

Background:

• Aberrant expression of dystrophin, utrophin, dysferlin, and calpain-3 is linked to muscular dystrophies (MDs).
• These proteins are increasingly recognized for potential tumor suppressor roles in various cancers.
• Cancer hallmarks like DNA damage and aneuploidy are observed in MDs, suggesting a shared pathway.

Purpose of the Study:

• To investigate the hypothesis that a common pathway involving the centrosome links muscular dystrophies and cancer.
• To determine if MD-related proteins are functional constituents of the centrosome.
• To explore the role of these proteins in both myogenic and non-myogenic cells.

Main Methods:

• Immunofluorescence and cell biological assays were used to examine protein localization and function at the centrosome.
• Myoblasts and non-myogenic cells were utilized to assess the impact of protein deficiency on centrosome integrity and function.
• Analysis included centrosome number, orientation, nuclear abnormalities, and microtubule nucleation.

Main Results:

• Dystrophin, utrophin, dysferlin, and calpain-3 were confirmed as functional components of the centrosome.
• Loss of any of these proteins in myoblasts led to centrosome amplification, misorientation, nuclear abnormalities, and impaired microtubule nucleation.
• These defects were exacerbated in dystrophin double-mutant cells.
• All four proteins, including muscle-specific dystrophin isoforms, were found to localize to the centrosome in non-myogenic cells.

Conclusions:

• Muscular dystrophy-related proteins share a conserved centrosome function beyond their muscle-specific roles.
• Defects at the centrosome underlie muscular dystrophies, presenting cancer-like cellular abnormalities.
• This research establishes a novel link between muscular dystrophies and cancer through shared centrosome-related pathways.